...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis
【24h】

Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis

机译:呼出的一氧化氮不是肺结核的生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

To reduce transmission of tuberculosis (TB) in resource-limited countries where TB remains a major cause of mortality, novel diagnostic tools are urgently needed. We evaluated the fractional concentration of exhaled nitric oxide (FeNO) as an easily measured, noninvasive potential biomarker for diagnosis and monitoring of treatment response in participants with pulmonary TB including multidrug resistant-TB in Lima, Peru. In a longitudinal study however, we found no differences in baseline median FeNO levels between 38 TB participants and 93 age-matched controls (13 parts per billion [ppb] [interquartile range (IQR) = 8-26] versus 15 ppb [IQR = 12-24]), and there was no change over 60 days of treatment (15 ppb [IQR = 10-19] at day 60). Taking this and previous evidence together, we conclude FeNO is not of value in either the diagnosis of pulmonary TB or as a marker of treatment response.
机译:减少TB仍然是死亡率的主要原因的资源有限的国家中结核病(TB),迫切需要小说诊断工具。 我们评估了呼出的一氧化氮(FENO)的分数浓度,作为易于测量的非侵入性潜在生物标志物,用于诊断和监测参与者的肺结核参与者治疗反应,包括在秘鲁的Mulima,秘鲁的多药抗性TB。 然而,在一个纵向研究中,我们发现38 TB参与者和93岁匹配的对照之间的基线中位数水平没有差异(13个份匹配的对照(13个左右[PPB] [胎面范围(IQR)= 8-26]而不是15 PPB [IQR = 12-24]),并且在60天的治疗中没有变化(第60天的15 ppb [IQR = 10-19])。 将此和以前的证据在一起,我们得出结论FENO在肺结核诊断或作为治疗反应的标志物中的价值不是价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号